Kusumam Joseph Selected Research

Androgens

1/2021

Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kusumam Joseph Research Topics

Disease

15	Hereditary Angioedemas 01/2022 - 01/2002
11	Angioedema 01/2024 - 01/2002
5	Asthma (Bronchial Asthma) 01/2024 - 01/2002
4	Choroidal Neovascularization 01/2021 - 05/2013
3	Anaphylaxis (Anaphylactic Shock) 01/2024 - 02/2002
3	Chronic Urticaria 09/2008 - 04/2005
2	Hypotension (Low Blood Pressure) 01/2024 - 02/2002
2	Urticaria (Hives) 07/2015 - 09/2008
2	Macular Degeneration (Age-Related Maculopathy) 01/2015 - 05/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 01/2005
2	Inflammation (Inflammations) 01/2005 - 02/2002
1	Laryngeal Edema 01/2024
1	Airway Obstruction (Choking) 01/2024
1	Factor XII Deficiency 01/2022
1	Thrombosis (Thrombus) 06/2021
1	Retinal Degeneration 01/2021
1	Infections 07/2017
1	Neoplasms (Cancer) 11/2016
1	Hypersensitivity (Allergy) 01/2014
1	Hereditary Angioedema Types I and II 08/2013
1	Cough 01/2005
1	Septic Shock (Toxic Shock Syndrome) 01/2005
1	Stroke (Strokes) 01/2005
1	Nasal Polyps (Nasal Polyp) 11/2004
1	Polyps 11/2004
1	Heart Failure 02/2002
1	Allergic Rhinitis 02/2002
1	Hypertension (High Blood Pressure) 02/2002
1	Bronchial Hyperreactivity 01/2002

Drug/Important Bio-Agent (IBA)

14	BradykininIBA 01/2024 - 01/2002
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024 - 01/2002
5	Factor XII (Hageman Factor)IBA 01/2022 - 09/2008
5	Complement System Proteins (Complement)IBA 01/2021 - 04/2005
4	PrekallikreinIBA 07/2017 - 09/2008
3	KininsIBA 11/2016 - 06/2010
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2024 - 06/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2024 - 01/2014
2	Immunoglobulin E (IgE)IBA 01/2024 - 09/2008
2	CytokinesIBA 07/2017 - 11/2004
2	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 07/2017 - 09/2008
2	A-factor (Streptomyces)IBA 07/2017 - 01/2016
2	Kallikreins (Kallikrein)IBA 10/2016 - 08/2013
2	Factor XIIa (Coagulation Factor XIIa)IBA 10/2016 - 03/2010
2	Omalizumab (Xolair)FDA Link 07/2015 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2010
2	AutoantibodiesIBA 09/2008 - 09/2007
2	IgE Receptors (Fc epsilon RI)IBA 09/2008 - 04/2005
2	Immunoglobulin G (IgG)IBA 09/2008 - 04/2005
1	AntigensIBA 01/2024
1	Monoclonal AntibodiesIBA 02/2022
1	Indicators and Reagents (Reagents)IBA 02/2022
1	Kininogens (Kininogen)IBA 01/2022
1	AndrogensIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	SmokeIBA 01/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2017
1	Fibrinolysin FDA Link 07/2017
1	Estrogens (Estrogen)FDA Link 07/2017
1	Interleukin-1 (Interleukin 1)IBA 07/2017
1	PlasminogenIBA 07/2017
1	PlasticsIBA 10/2016
1	AnaphylatoxinsIBA 03/2016
1	Plasminogen Activator Inhibitor 2IBA 01/2016
1	Angiotensin Receptor AntagonistsIBA 06/2015
1	Enalapril FDA LinkGeneric 06/2015
1	Complement Factor B (Factor B)IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	Proteoglycans (Proteoglycan)IBA 01/2014
1	CryoglobulinsIBA 01/2014
1	AntibodiesIBA 05/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2013
1	Plasma KallikreinIBA 03/2010
1	Blood Proteins (Serum Proteins)IBA 03/2010
1	KaolinIBA 09/2008
1	Interleukin-13IBA 11/2004
1	ChemokinesIBA 11/2004
1	Interleukin-5 (Interleukin 5)IBA 11/2004
1	SteroidsIBA 11/2004
1	Chemotactic FactorsIBA 11/2004
1	Heparin (Liquaemin)FDA LinkGeneric 02/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 07/2015
2	Lasers (Laser) 01/2015 - 05/2013